Invention Grant
- Patent Title: Survival predictor for diffuse large B cell lymphoma
-
Application No.: US15965510Application Date: 2018-04-27
-
Publication No.: US11028444B2Publication Date: 2021-06-08
- Inventor: Lisa M. Rimsza , Andrew T. Lister , Wing C. Chan , Dennis Weisenburger , Jan Delabie , Erlend B. Smeland , Harald Holte , Stein Kvaløy , Rita M. Braziel , Richard I. Fisher , Pedro Jares , Armando Lopez-Guillermo , Elias Campo Guerri , Elaine S. Jaffe , Georg Lenz , Wyndham H. Wilson , George W. Wright , Sandeep S. Dave , Louis M. Staudt , Randy D. Gascoyne , Joseph M. Connors , Hans-Konrad Muller-Hermelink , Andreas Rosenwald , German Ott
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services , Arizona Board of Regents on Behalf of the University of Arizona , Queen Mary University of London , Board of Regents of the University of Nebraska , Oslo University Hospital HF , Oregon Health & Science University , University of Rochester , Hospital Clinic de Barcelona , Universitat de Barcelona , British Columbia Cancer Agency Branch , Julius-Maximilians-University of Würzburg
- Applicant Address: US MD Bethesda; US AZ Tucson; GB London; US NE Lincoln; NO Oslo; US OR Portland; US NY Rochester; ES Barcelona; ES Barcelona; CA Vancouver; DE Würzburg
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,Arizona Board of Regents on Behalf of the University of Arizona,Queen Mary University of London,Board of Regents of the University of Nebraska,Oslo University Hospital HF,Oregon Health & Science University,University of Rochester,Hospital Clinic de Barcelona,Universitat de Barcelona,British Columbia Cancer Agency Branch,Julius-Maximilians-University of Würzburg
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,Arizona Board of Regents on Behalf of the University of Arizona,Queen Mary University of London,Board of Regents of the University of Nebraska,Oslo University Hospital HF,Oregon Health & Science University,University of Rochester,Hospital Clinic de Barcelona,Universitat de Barcelona,British Columbia Cancer Agency Branch,Julius-Maximilians-University of Würzburg
- Current Assignee Address: US MD Bethesda; US AZ Tucson; GB London; US NE Lincoln; NO Oslo; US OR Portland; US NY Rochester; ES Barcelona; ES Barcelona; CA Vancouver; DE Würzburg
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: G01N33/48
- IPC: G01N33/48 ; C12Q1/6886 ; G01N33/574
Abstract:
The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.
Public/Granted literature
- US20180245165A1 SURVIVAL PREDICTOR FOR DIFFUSE LARGE B CELL LYMPHOMA Public/Granted day:2018-08-30
Information query
